Abstract
Whether an association exists between the use of gonadotropin-releasing hormone (GnRH) analog and blastocyst euploidy rate as well as clinical pregnancy rate in preimplantation genetic testing for aneuploidy (PGT-A) cycles.
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have